Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 10
1987 1
1988 3
1989 1
1990 2
1991 7
1992 3
1993 13
1994 3
1995 3
1996 4
1997 4
1998 5
1999 5
2000 3
2001 5
2002 7
2003 5
2004 7
2005 4
2006 5
2007 4
2008 5
2009 3
2010 4
2011 5
2012 6
2013 5
2014 3
2015 1
2016 1
2017 5
2018 3
2019 1
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Prednicarbate.
[No authors listed] [No authors listed] 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999715 Free Books & Documents. Review.
Topical prednicarbate has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the bre …
Topical prednicarbate has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids …
Prednicarbate (Dermatop): profile of a corticosteroid.
Gupta AK, Chow M. Gupta AK, et al. J Cutan Med Surg. 2004 Jul-Aug;8(4):244-7. doi: 10.1007/s10227-004-0120-x. J Cutan Med Surg. 2004. PMID: 16092003 Review.
METHODS: Published literature containing the word "prednicarbate" was examined and summarized. RESULTS: Prednicarbate is a nonhalogenated, double-ester derivative of prednisolone that has been used in the treatment of inflammatory and pruritic manifestations of cort …
METHODS: Published literature containing the word "prednicarbate" was examined and summarized. RESULTS: Prednicarbate is a non …
A review of prednicarbate (Dermatop).
Gupta AK, Chow M. Gupta AK, et al. Skin Therapy Lett. 2004 Dec-2005 Jan;9(10):5-6, 9. Skin Therapy Lett. 2004. PMID: 15657633 Free article. Review.
Prednicarbate is a nonhalogenated corticosteroid that is used in the treatment of inflammatory skin diseases, for example atopic dermatitis. It has a favorable benefit-risk ratio, with an inflammatory action similar to that of a medium potency corticosteroid, but with a lo …
Prednicarbate is a nonhalogenated corticosteroid that is used in the treatment of inflammatory skin diseases, for example atopic derm …
Prednicarbate contact allergy.
Villas Martínez F, Navarro Echeverría JA, Joral Badás A, Garmendia Goitia FJ. Villas Martínez F, et al. Contact Dermatitis. 1997 Dec;37(6):299-300. doi: 10.1111/j.1600-0536.1997.tb02472.x. Contact Dermatitis. 1997. PMID: 9455638 No abstract available.
Prednicarbate (dermatop): a review.
Gupta AK, Chow M. Gupta AK, et al. J Drugs Dermatol. 2004 Sep-Oct;3(5):553-6. J Drugs Dermatol. 2004. PMID: 15552608 Review.
Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis. ...Prednicarbate may be particularly advantageous when used intermittently in pedi …
Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflamma …
Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
Spencer CM, Wagstaff AJ. Spencer CM, et al. BioDrugs. 1998 Jan;9(1):61-86. doi: 10.2165/00063030-199809010-00006. BioDrugs. 1998. PMID: 18020557
Prednicarbate is a synthetic nonhalogenated moderate to high potency corticosteroid. ...Smaller trials, conducted in patients with dermatitis, show prednicarbate generally to have similar activity to comparator corticosteroids. ...
Prednicarbate is a synthetic nonhalogenated moderate to high potency corticosteroid. ...Smaller trials, conducted in patients with de …
Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.
de Tiedra A, Mercadal J, Lozano R. de Tiedra A, et al. Pharmacoeconomics. 1997 Aug;12(2 Pt 1):193-208. doi: 10.2165/00019053-199712020-00009. Pharmacoeconomics. 1997. PMID: 10169671 Clinical Trial.
A sensitivity analysis was carried out on the basis of changes in: (i) clinical effectiveness; (ii) price of prednicarbate; (iii) incidence of adverse reactions; (iv) costs associated with ineffectiveness and/or adverse effects; and (v) the regimen under which prednicar …
A sensitivity analysis was carried out on the basis of changes in: (i) clinical effectiveness; (ii) price of prednicarbate; (iii) inc …
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M, Korting HC, Kerscher MJ, Lenhard S. Schäfer-Korting M, et al. Clin Pharmacol Ther. 1993 Oct;54(4):448-56. doi: 10.1038/clpt.1993.172. Clin Pharmacol Ther. 1993. PMID: 8222488 Clinical Trial.
Prednicarbate and its vehicle, however, do not reverse irritant dermatitis. The benefit/risk ratios of prednicarbate and hydrocortisone aceponate exceed those with betamethasone 17-valerate. ...
Prednicarbate and its vehicle, however, do not reverse irritant dermatitis. The benefit/risk ratios of prednicarbate and hydro …
Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination?
Korting HC, Zienicke H, Braun-Falco O, Bork K, Milbradt R, Nolting S, Schöpf E, Tronnier H. Korting HC, et al. Infection. 1994 Nov-Dec;22(6):390-4. doi: 10.1007/BF01715495. Infection. 1994. PMID: 7698835 Review.
One of the preparations was used twice daily over 5 days according to a random plan in a blind fashion. Thereafter treatment was based on either prednicarbate cream or the corresponding vehicle according to clinical needs. ...Essentially, there was no difference between th …
One of the preparations was used twice daily over 5 days according to a random plan in a blind fashion. Thereafter treatment was based on ei …
Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
Gysler A, Lange K, Korting HC, Schäfer-Korting M. Gysler A, et al. Pharm Res. 1997 Jun;14(6):793-7. doi: 10.1023/a:1012162708675. Pharm Res. 1997. PMID: 9210199
PURPOSE: Evaluation of skin layer-specific prednicarbate (PC) biotransformation, possibly explaining the improved benefit/risk ratio of this topical corticosteroid in atopic dermatitis (1,2). ...
PURPOSE: Evaluation of skin layer-specific prednicarbate (PC) biotransformation, possibly explaining the improved benefit/risk ratio …
140 results